Company

Amniotics AB

Headquarters: Lund, Sweden

Employees: 21

OMX: AMNI

Detailed Description

Amniotics AB, a biopharma company, develops, manufactures, and sells stem cell therapies based on mesenchymal stem cells to treat severe life-threatening diseases. The company's lead drug candidate is PulmoStem for the treatment of inflammatory and fibrotic lung disease. It also develops CogniStem for the treatment of CNS indications; NephroStem for the treatment of kidney-specific indications; and CutiStem for the treatment of dermatological indications. The company offers contract development and contract manufacturing services for advanced therapy medicinal products to the pharmaceutical industries, universities, and hospitals. Amniotics AB was incorporated in 2015 and is based in Lund, Sweden.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Amniotics AB has the following listings and related stock indices.


Stock: OMX: AMNI wb_incandescent

Details

Headquarters:

Scheelevägen 2

Lund, 22381

Sweden

Phone: 46 7 23 27 85 20